Related Experiment Video

Updated: Aug 12, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Glucocorticoids modulate rat hypothalamic corticotrophin-releasing factor release induced by interleukin-1

J C Cambronero1, J Borrell, C Guaza

  • 1Department of Psychobiology, Cajal Institute, CSIC, Madrid, Spain.

Journal of Neuroscience Research
|December 1, 1989
PubMed

Insights

Interleukin-1 beta (IL-1) stimulates corticotropin-releasing factor (CRF) secretion in rats, but this effect is reduced by dexamethasone. This suggests an immune-neuroendocrine pathway is key for homeostasis.

Area of Science:

  • Neuroendocrinology
  • Immunology
  • Homeostasis

Background:

  • The hypothalamus plays a crucial role in the stress response and maintaining homeostasis.
  • Interleukin-1 beta (IL-1) is a cytokine involved in immune responses that can also affect the neuroendocrine system.
  • Glucocorticoids, like dexamethasone, are key regulators of the stress axis.

Purpose of the Study:

  • To investigate the effect of IL-1 beta on corticotropin-releasing factor (CRF) secretion from the rat hypothalamus.
  • To examine the modulatory role of dexamethasone on IL-1 beta-induced CRF secretion.
  • To elucidate the role of immunoneuroendocrine interactions in maintaining homeostasis.

Main Methods:

  • Continuous in vitro perifusion of rat hypothalami.
  • Administration of varying doses of IL-1 beta (1-5 U/ml) during perifusion.
  • Treatment with dexamethasone, both in vitro (perifusion medium) and in vivo (pretreatment).
  • Measurement of CRF secretion.

Main Results:

  • IL-1 beta significantly increased CRF secretion in a dose-dependent manner.
  • Dexamethasone significantly attenuated the stimulatory effect of IL-1 beta on CRF secretion.
  • This attenuation was observed with both in vitro and in vivo dexamethasone administration.

Conclusions:

  • IL-1 beta stimulates CRF secretion, indicating a role for immune signaling in neuroendocrine function.
  • Glucocorticoid negative feedback, via dexamethasone, effectively modulates this IL-1 beta-induced response.
  • An immunoneuroendocrine interaction circuit, regulated by glucocorticoids, is essential for maintaining organism homeostasis.

More Related Videos

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...